Drug delivery to and through the skin

DOI: https://doi.org/10.1007/s13346-024-01614-w

2024-06-06

Drug Delivery and Translational Research

Abstract:Drug delivery technology has advanced significantly over >50 years, and has produced remarkable innovation, countless publications and conferences, and generations of talented and creative scientists. However, a critical review of the current state-of-the-art reveals that the translation of clever and sophisticated drug delivery technologies into products, which satisfy important, unmet medical needs and have been approved by the regulatory agencies, has - given the investment made in terms of time and money - been relatively limited. Here, this point of view is illustrated using a case study of technology for drug delivery into and through the skin and aims: to examine the historical development of this field and the current state-of-the-art; to understand why the translation of drug delivery technologies into products that improve clinical outcomes has been quite slow and inefficient; and to suggest how the impact of technology may be increased and the process of concept to approved product accelerated.

pharmacology & pharmacy,medicine, research & experimental

What problem does this paper attempt to address?

The paper primarily explores the development of transdermal drug delivery technologies and the challenges and opportunities in drug transmission. Specifically, the paper attempts to address the following key issues:

1. **Historical Development and Current Status**: Review the historical development of transdermal drug delivery technologies and assess the current technological level.

2. **Translation Challenges**: Analyze why many advanced transdermal drug delivery technologies have failed to successfully translate into actual products, especially those that can improve clinical outcomes.

3. **Enhancing Technological Impact**: Propose ways to enhance the impact of these technologies and accelerate the process from concept to approved product.

The paper points out that despite significant progress in transdermal drug delivery technologies over the past 50 years, there are still considerable difficulties in translating these technologies into actual products that meet important medical needs. These issues involve not only the technology itself but also regulatory approval, safety, and patient acceptance. Additionally, the paper discusses the application and challenges of various methods (such as chemical enhancers, iontophoresis, microneedle technology, etc.) in the field of transdermal drug delivery. Overall, the paper aims to promote the development of transdermal drug delivery technologies and propose improvements to better meet clinical needs.